These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12111188)

  • 1. Circulating anti-prolactin auto-antibodies must be considered in the differential diagnosis of hyperprolactinaemia in adolescents.
    Vanbesien J; Schiettecatte J; Anckaert E; Smitz J; Velkeniers B; De Schepper J
    Eur J Pediatr; 2002 Jul; 161(7):373-6. PubMed ID: 12111188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of anti-PRL (prolactin) autoantibodies by homologous PRL in rats: a model for macroprolactinemia.
    Hattori N; Nakayama Y; Kitagawa K; Li T; Inagaki C
    Endocrinology; 2007 May; 148(5):2465-70. PubMed ID: 17303669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-prolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia.
    Leaños A; Pascoe D; Fraga A; Blanco-Favela F
    Lupus; 1998; 7(6):398-403. PubMed ID: 9736323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity.
    Leaños-Miranda A; Pascoe-Lira D; Chávez-Rueda KA; Blanco-Favela F
    J Rheumatol; 2001 Jul; 28(7):1546-53. PubMed ID: 11469460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus.
    Leaños-Miranda A; Chávez-Rueda KA; Blanco-Favela F
    Arthritis Rheum; 2001 Apr; 44(4):866-75. PubMed ID: 11315926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macroprolactin; high molecular mass forms of circulating prolactin.
    Fahie-Wilson MN; John R; Ellis AR
    Ann Clin Biochem; 2005 May; 42(Pt 3):175-92. PubMed ID: 15949152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-prolactin autoantibodies on serum prolactin measurements.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):434-7. PubMed ID: 8180668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibody to human prolactin in patients with idiopathic hyperprolactinemia.
    Hattori N; Ishihara T; Ikekubo K; Moridera K; Hino M; Kurahachi H
    J Clin Endocrinol Metab; 1992 Nov; 75(5):1226-9. PubMed ID: 1430082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered diurnal rhythm of prolactin in systemic sclerosis.
    Hilty C; Brühlmann P; Sprott H; Gay RE; Michel BA; Gay S; Neidhart M
    J Rheumatol; 2000 Sep; 27(9):2160-5. PubMed ID: 10990228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins.
    Ram S; Harris B; Fernando JJ; Gama R; Fahie-Wilson M
    Ann Clin Biochem; 2008 May; 45(Pt 3):256-9. PubMed ID: 18482912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies against prolactin in patients with systemic lupus erythematosus and hyperprolactinemia].
    Leaños Miranda L; Bustos López HH; Fraga Mouret A; Blanco Favela F; Dalila Pascoe Lira ME; Dalila Pascoe Lira C
    Ginecol Obstet Mex; 1998 May; 66():179-86. PubMed ID: 9646575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex.
    Hattori N; Inagaki C
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3107-10. PubMed ID: 9284753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia.
    Le Moli R; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):44-8. PubMed ID: 12735420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes.
    De Schepper J; Schiettecatte J; Velkeniers B; Blumenfeld Z; Shteinberg M; Devroey P; Anckaert E; Smitz J; Verdood P; Hooghe R; Hooghe-Peters E
    Eur J Endocrinol; 2003 Sep; 149(3):201-7. PubMed ID: 12943522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the antibody titers with serum prolactin levels and their clinical course in patients with anti-prolactin autoantibody.
    Hattori N; Ikekubo K; Ishihara T; Moridera K; Hino M; Kurahachi H
    Eur J Endocrinol; 1994 May; 130(5):438-45. PubMed ID: 8180669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macroprolactinaemia in patients with hyperprolactinaemia: composition of macroprolactin and stability during long-term follow-up.
    Hattori N; Ishihara T; Saiki Y; Shimatsu A
    Clin Endocrinol (Oxf); 2010 Dec; 73(6):792-7. PubMed ID: 20874771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macroprolactinemia in childhood and adolescence: a cause of hyperprolactinemia.
    Tütüncüler F; Darendeliler F; Aygün M; Hekim N
    Turk J Pediatr; 2006; 48(2):143-7. PubMed ID: 16848115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of hyperprolactinaemia with the use of the intervals for prolactin after macroforms separation.
    Beda-Maluga K; Pisarek H; Komorowski J; Swietoslawski J; Fuss-Chmielewska J; Winczyk K
    J Physiol Pharmacol; 2014 Jun; 65(3):359-64. PubMed ID: 24930507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.